|
Lyme/LYMErix Cryme
Reveals New Paradigm in
Health/Disease:
"Bacterial/Viral Coinfections"; TLR2 (fungi)Signaling Depletes IRAK1 and Inhibits Induction of Type 1 by TLR7/9 (viruses)-- -CV Harding, 2012 (More in the chart at the bottom of this homepage) "Multiple Mechanisms of Immune Suppression by B Lymphocytes" (New and Trashes Yale and IDSA) NIH's Treatment Recommendations for Chronic Active Epstein-Borreliosis, the chronic illness also induced by OspA vaccination or exposure to molds.
ELISA = arbitrary cutoff. 1998, CIA Oilmen & Israelis plan to overthrow Saddam for the oil.
Bush/Gore Oil/War-(Oct,2000)
|
Lyme Disease Public Conference Saturday April 22, 2006 Clinton Library, 10 AM to 1 PM
The Hartford and Southeastern Connecticut Lyme disease support groups present: “Lyme Disease, The Cause, The Cure, and The Controversy”
Program: Providing the tools and resources to the public
* Scientific Validity- a well-defined concept accuracy, specificity, precision, ruggedness, LOQ, linearity
* Lyme is a relapsing fever borreliosis The only difference is OspA and hard-bodied ticks.
* The only validated test for Borreliosis is Borrelia-specific flagellin Developed in early 1990s by several groups. Validated by Yale in 1991, patent applied for in 1993 (US patent 5,618,533) Phylogeny, taxonomy
* OspA (LYMErix) was a vaccine against inflammatory Lyme arthritis Originally, OspA antibodies were associated with arthritis. OspA was then mysteriously left out of the testing standard. The CDC’s Dearborn Conference 1994
* Borreliae are “stealth pathogens” and not primarily inflammatory diseases Relapsing Fever: no vaccine due to antigenic variation; Justin Radolf and syphilis; “mucopeptides” Borrelioses are permanent brain infections
* Inflammation vs. Tolerance; Mechanisms of Immune Suppression Pam3Cys (triacyl lipopeptides)
* Mechanisms of Illness (markers of disease) GFap, MMPs, cytokines, other antibodies, EMGs, quinolinic acid, SPECT and PET scans, MRI, Lyme and Multiple Sclerosis, Lyme and “psychiatric” illnesses. |